More about

Nemours/Alfred I. Dupont Hospital For Children

News
April 11, 2023
2 min read
Save

Several personal, professional factors may contribute to burnout among orthopedic surgeons

Several personal and professional factors, including sex, race and work hours, may contribute to a higher risk of burnout among orthopedic surgeons, according to published results.

News
March 01, 2023
1 min read
Save

Transition to brace after casting for early onset scoliosis may improve quality of life

Patients treated with casting for early onset scoliosis experienced declines in health-related quality of life that were reversible after transitioning from casting to bracing, according to published results.

News
August 09, 2022
3 min read
Save

App targets mental health after prenatal diagnosis of congenital heart disease

A psychosocial intervention delivered via a mobile app reduced distress and helped prepare pregnant women and their partners after a fetal diagnosis of congenital heart disease, according to data from a pilot study.

News
August 18, 2021
2 min read
Save

Sleep apnea common, may impact CVD in children, adolescents

According to a scientific statement published in the Journal of the American Heart Association, obstructive sleep apnea is common among children and adolescents and may be associated with BP and heart structure.

News
August 04, 2021
3 min read
Save

Hypoglycemia fear, family conflict influence HbA1c trends in children with type 1 diabetes

Parent-reported hypoglycemia fear and diabetes-specific family conflict may predict HbA1c trajectories for children aged 5 to 9 years with recent-onset type 1 diabetes, according to findings published in Diabetic Medicine.

News
May 29, 2021
2 min read
Save

Twice-yearly leuprolide slows bone maturation in central precocious puberty

A subcutaneous injection of leuprolide acetate every 6 months was effective and well tolerated in treating central precocious puberty in children, according to trial data.

News
March 31, 2021
1 min read
Save

FDA approves Vyxeos for secondary acute myeloid leukemia in children

The FDA expanded the approval of daunorubicin and cytarabine to include the treatment of children aged at least 1 year with newly diagnosed therapy-related acute myeloid leukemia, according to a manufacturer-issued press release.